Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites

J Craniomaxillofac Surg. 2005 Feb;33(1):50-4. doi: 10.1016/j.jcms.2004.05.011. Epub 2005 Jan 11.

Abstract

Aim: Several injectable materials have been used as osteogenic bone substitutes. However, none has gained universal acceptance. This study was performed to investigate whether or not chitosan-alginate gel/mesenchymal stem cells/bone morphogenetic protein-2 composites are potentially injectable materials for new bone formation.

Material and methods: The composites were injected into the subcutaneous space on the dorsum of nude mice to investigate new bone tissue formation. The composites were examined histologically over a 12-week period.

Results: The composites injected into the mouse were able to stimulate new bone formation, which was trabecular in type.

Conclusions: This study showed that chitosan-alginate gel/MSCs/BMP-2 composites could become clinically useful injectable materials to generate new bone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates / administration & dosage
  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins / administration & dosage
  • Bone Regeneration / drug effects
  • Bone Substitutes / administration & dosage*
  • Bone Substitutes / chemistry
  • Chitosan / administration & dosage
  • Gels
  • Glucuronic Acid / administration & dosage
  • Hexuronic Acids / administration & dosage
  • Mesenchymal Stem Cells / chemistry
  • Mice
  • Mice, Nude
  • Transforming Growth Factor beta / administration & dosage

Substances

  • Alginates
  • Bmp2 protein, mouse
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Bone Substitutes
  • Gels
  • Hexuronic Acids
  • Transforming Growth Factor beta
  • Glucuronic Acid
  • Chitosan